Niger

in page functions
Total population (2012)16,644,339
Birth cohort (2012)799,712
Surviving Infants (surviving to 1 year per year, 2012)730,567
Infant mortality rate (deaths < 1 year per 1000 births, 2011)66.40/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)124.50/1000
World Bank Index, IDA (2012)3.39
Gross Nation Income (per capita US$, 2011)360
Co-financing status (2012)Low-income
No. of districts/territories (2011)42
Download this page as a PDF factsheet

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Niger

Type of support

Approvals

2001-2016 (US$)
(30 Apr 2013)

Commitments

2001-2016 (US$)
(30 Apr 2013)

Disbursements

2001-2012 (US$)
(30 Apr 2013)

% Disbursed

(30 Apr 2013)
20022003200420052006200720082009201020112012201320142015
Cash Support$235,000$260,000
Health System Strengthening (HSS)$3,986,000$3,986,000$3,986,000100%
HPV Demo (NVS)$665,000$665,000
Immunisation Services Support (ISS)$9,509,600$9,509,600$9,509,600100%
Injection Safety Support (INS)$943,757$943,757$943,757100%
Penta (NVS)$35,618,806$47,304,306$34,316,68196%
Pneumo (NVS)$10,118,000$37,643,500
Rotavirus (NVS)0$11,179,000N/A
Vaccine Introduction Grant$2,061,500$2,061,500$506,00025%
Yellow Fever (NVS)$2,014,792$3,872,292$2,143,956106%
Total$65,152,455$117,424,955$51,405,995

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence		75%

*
DTP3 - Official country estimates (2011)97%
M:F sex ratio at birth (2012)1.05
Household survey: DTP3 coverage for male (2010)67.50%
Household survey: DTP3 coverage for female (2010)68.60%
Household survey: Last DTP3 survey (2010)68%
% districts achieving > 80% DTP3 coverage (2011)90%
% districts achieving < 50% DTP3 coverage (2011)0%
MCV WHO/UNICEF estimates (2011)76%
Polio WHO/UNICEF estimates (2011)44%

Breakdown of support

Non-vaccine supportVaccine support
29% 71%
$14,945,357 $36,460,637

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

14 May 2013

Mariam

Kenya first country to protect girls against cervical cancer with GAVI support

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

08 May 2013

GAVI HPV Vaccine Infographic

Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals

Historic agreements show power of innovative public-private partnership

04 February 2013

HPV

GAVI funds vaccines to protect girls against cervical cancer

More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks to human papillomavirus (HPV) vaccines funded by the GAVI Alliance.

Useful links

View all sources for data in this page
close icon

modal window here